Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
Research ArticleArticle

Effect of Atorvastatin on Inflammation and Modification of Vascular Risk Factors in Rheumatoid Arthritis

AMAL M. EL-BARBARY, MANAL S. HUSSEIN, ELSAYED M. RAGEH, HALA E. HAMOUDA, AYMAN A. WAGIH and RAGHDA G. ISMAIL
The Journal of Rheumatology February 2011, 38 (2) 229-235; DOI: https://doi.org/10.3899/jrheum.100582
AMAL M. EL-BARBARY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ml_barbary@yahoo.com
MANAL S. HUSSEIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELSAYED M. RAGEH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HALA E. HAMOUDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYMAN A. WAGIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAGHDA G. ISMAIL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Theis KA,
    2. Helmick CG,
    3. Hootman JM
    . Arthritis burden and impact are greater among U.S. women than men: intervention opportunities. J Womens Health 2007;16:441–53.
    OpenUrlCrossRef
  2. 2.↵
    1. Sattar N,
    2. McCarey DW,
    3. Capell H,
    4. McInnes IB
    . Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957–63.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Guzik TJ,
    2. Mangalat D,
    3. Korbut R
    . Adipocytokines — novel link between inflammation and vascular function? J Physiol Pharmacol 2006;57:505–28.
    OpenUrlPubMed
  4. 4.↵
    1. Locksley RM,
    2. Killeen N,
    3. Lenardo MJ
    . The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:487–501.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Steppan CM,
    2. Bailey ST,
    3. Bhat S,
    4. Brown EJ,
    5. Banerjee RR,
    6. Wright CM,
    7. et al.
    The hormone resistin links obesity to diabetes. Nature 2001;409:307–12.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Silswal N,
    2. Singh AK,
    3. Aruna B,
    4. Mukhopadhyay S,
    5. Ghosh S,
    6. Ehtesham NZ
    . Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappa B-dependent pathway. Biochem Biophys Res Commun 2005;334:1092–101.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Blanco-Colio LM,
    2. Martín-Ventura JL,
    3. Gómez-Guerrero C,
    4. Masramon X,
    5. de Teresa Farsang C,
    6. Gaw A,
    7. et al.
    Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk. Eur J Pharmacol 2008;31:259–65.
    OpenUrl
  8. 8.↵
    1. Baskol G,
    2. Demir H,
    3. Baskol M,
    4. Kilic E,
    5. Ates F,
    6. Kocer D,
    7. et al.
    Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005;38:951–5.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Singh U,
    2. Jialal I
    . Oxidative stress and atherosclerosis. Pathophysiology 2006;13:129–42.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Celermajer DS,
    2. Sorensen KE,
    3. Gooch VM,
    4. Spiegelhalter DJ,
    5. Miller OI,
    6. Sullivan ID
    . Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–5.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Blann AD
    . Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagula Fibrinolysis 2000;11:623–30.
    OpenUrlCrossRef
  12. 12.↵
    1. Corretti MC,
    2. Anderson TJ,
    3. Benjamin EJ,
    4. Celermajer D,
    5. Charbonneau F,
    6. Creager MA
    . Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257–65.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Shepherd J,
    2. Hunninghake DB,
    3. Barter P,
    4. Mckenney,
    5. Hutchinson E
    . Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin and simvastatin for achieving lipid lowering goals. Am J Cardiol 2003;91:11C–19C.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Vishal T,
    2. Bano G,
    3. Khajuria V,
    4. Parihar A,
    5. Gupta S
    . Pleiotropic effects of statins. Ind J Pharmacol 2003;37:77–85.
    OpenUrl
  15. 15.↵
    1. Arnett FC,
    2. Edworthy SM,
    3. Bloch DA,
    4. McShane DJ,
    5. Fries JF,
    6. Cooper NS,
    7. et al.
    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Prevoo ML,
    2. van ’t Hof MA,
    3. Kuper HH,
    4. van Leeuwen MA,
    5. van de Putte LP,
    6. van Riel PL
    . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. van Gestel AM,
    2. Anderson JJ,
    3. van Riel PL,
    4. Boers M,
    5. Haagsma CJ,
    6. Rich B,
    7. et al.
    ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J Rheumatol 1999;26:705–11.
    OpenUrlPubMed
  18. 18.↵
    1. Pinckard JK,
    2. Sheehan KCF,
    3. Schreiber RD
    . Ligand induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J Biol Chem 1997;272:10784–9.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Chen D,
    2. Fang Q,
    3. Chai Y,
    4. Wang H,
    5. Huang H,
    6. Dong M
    . Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol 2007;67:208–11.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Arita Y,
    2. Kihara S,
    3. Ouchi N,
    4. Takahashi M,
    5. Maeda K,
    6. Miyagawa J,
    7. et al.
    Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79–83.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Satoch K
    . Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta 1978;90:37–43.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Heldenberg D,
    2. Caspi D,
    3. Levtov O,
    4. Werbin B,
    5. Fishel B,
    6. Yaron M
    . Serum lipids and lipoprotein concentrations in women with rheumatoid arthritis. Clin Rheumatol 1983;2:387–91.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Lorber M,
    2. Aviram M,
    3. Linn S,
    4. Sharf Y,
    5. Brook JG
    . Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis. Br J Rheumatol 1985;24:250–5.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Lakatos J,
    2. Harsagyi A
    . Serum total, HDL, LDL cholesterol and triglyceride levels in patients with rheumatoid arthritis. Clin Biochem 1988;21:93–6.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Kavanaugh A
    . Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis. Ann Rheum Dis 1994;53:551–2.
    OpenUrlFREE Full Text
  26. 26.↵
    1. Asanuma Y,
    2. Kawai S,
    3. Aoshima H,
    4. Kaburaki J,
    5. Mizushima Y
    . Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:443–7.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Georgiadis AN,
    2. Papavasiliou EC,
    3. Lourida ES,
    4. Alamanos Y,
    5. Kostara C,
    6. Tselepis AD,
    7. et al.
    Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment in a prospective, controlled study. Arthritis Res Ther 2006;8:R82.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Georgiadis AN,
    2. Voulgari PV,
    3. Argyropoulou MI,
    4. Alamanos Y,
    5. Elisaf M,
    6. Tselepis AD,
    7. et al.
    Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum 2008;38:13–9.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Hadda V,
    2. Handa R,
    3. Aggarwal P,
    4. Lakshmy R,
    5. Kumar U,
    6. Pandey RM
    . Disease activity and lipids in rheumatoid arthritis: a prospective study. Ind J Rheumatol 2007;2:137–40.
    OpenUrlCrossRef
  30. 30.↵
    1. McCarey DW,
    2. McInnes IB,
    3. Madhok R,
    4. Hampson R,
    5. Scherbakova O,
    6. Ford I,
    7. et al.
    Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015–21.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Alegret M,
    2. Silvestre JS
    . Pleiotropic effects of statins and related pharmacological experimental approaches. Methods Find Exp Clin Pharmacol 2006;28:627.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Save V,
    2. Patil N,
    3. Moulik N,
    4. Rajadhyaksha G
    . Effect of atorvastatin on type 2 diabetic dyslipidaemia. J Cardiovasc Pharmacol Ther 2006;11:262–70.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Istvan ES,
    2. Deisenhofer J
    . Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001;292:1160–4.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Seven A,
    2. Güzel S,
    3. Aslan M,
    4. Hamuryudan V
    . Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 2008;41:538–43.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Olivieri O,
    2. Girelli D,
    3. Trevisan MT,
    4. Bassi A,
    5. Zorzan P,
    6. Bambara LM,
    7. et al.
    Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patients with rheumatoid arthritis. J Rheumatol 1991;18:1263–4.
    OpenUrlPubMed
  36. 36.↵
    1. Akyol O,
    2. Isçi N,
    3. Temel I,
    4. Özgöçmen S,
    5. Uz E,
    6. Murat M,
    7. et al.
    The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001;68:311–7.
    OpenUrl
  37. 37.↵
    1. Liao JK,
    2. Laufs U
    . Pleiotropic effects of statins. Ann Rev Pharmacol Toxicol 2005;45:89–118.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Danesh FR,
    2. Kanwar YS
    . Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy. FASEB J 2004;18:805–15.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Nagila A,
    2. Permpongpaiboon T,
    3. Tantrarongroj S
    . Effect of atorvastatin on paraoxonase 1 (PON1) and oxidative status. Pharmacol Rep 2009;61:892–8.
    OpenUrlPubMed
  40. 40.↵
    1. Schäffler A,
    2. Ehling E,
    3. Neumann H,
    4. Herfarth H,
    5. Tarner I,
    6. Schölmerich J,
    7. et al.
    Adipocytokines in synovial fluid. JAMA 2003;290:1709–10.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Senolt L,
    2. Housa D,
    3. Vernerová Z,
    4. Jirásek T,
    5. Svobodová R,
    6. Veigl D,
    7. et al.
    Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007;66:458–63.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Shyu K,
    2. Chua S,
    3. Wang B,
    4. Kuan P
    . Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-α in macrophages. J Biomed Sci 2009;16:50.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Chu S,
    2. Ding W,
    3. Li K,
    4. Pang Y,
    5. Tang C
    . Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ J 2008;72:1249–53.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Senolt L,
    2. Pavelka K,
    3. Housa D,
    4. Haluzík M
    . Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006;35:247–52.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Otero M,
    2. Lago R,
    3. Gomez R,
    4. Lago F,
    5. Dieguez C,
    6. Gómez-Reino JJ,
    7. et al.
    Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1198–201.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Nakamura T,
    2. Kodama Y,
    3. Takano H,
    4. Umetani K,
    5. Fujioka D,
    6. Saito Y,
    7. et al.
    Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia. Atherosclerosis 2007;193:449–51.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Koh KK,
    2. Quon MJ,
    3. Han SH,
    4. Lee Y,
    5. Kim SJ,
    6. Park JB,
    7. et al.
    Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients. Atherosclerosis 2009;204:483–90.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Bruun JM,
    2. Lihn AS,
    3. Verdich C,
    4. Pedersen SB,
    5. Toubro S,
    6. Astrup A,
    7. et al.
    Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003;285:527–33.
    OpenUrl
  49. 49.↵
    1. Osei K,
    2. Gaillard T,
    3. Cook C,
    4. Kaplow J,
    5. Bullock M,
    6. Schuster D
    . Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone. Ethn Dis 2005;15:641–8.
    OpenUrlPubMed
  50. 50.↵
    1. Tomas JP,
    2. Moya JL,
    3. Campuzano R,
    4. Barrios V,
    5. Megías A,
    6. Ruiz S,
    7. et al.
    Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia. Rev Esp Cardiol 2004;57:909–15.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Mäki-Petäjä KM,
    2. Booth AD,
    3. Hall FC,
    4. Wallace SML,
    5. Brown J,
    6. McEniery CM,
    7. et al.
    Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007;50:852–8.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 2
1 Feb 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Atorvastatin on Inflammation and Modification of Vascular Risk Factors in Rheumatoid Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effect of Atorvastatin on Inflammation and Modification of Vascular Risk Factors in Rheumatoid Arthritis
AMAL M. EL-BARBARY, MANAL S. HUSSEIN, ELSAYED M. RAGEH, HALA E. HAMOUDA, AYMAN A. WAGIH, RAGHDA G. ISMAIL
The Journal of Rheumatology Feb 2011, 38 (2) 229-235; DOI: 10.3899/jrheum.100582

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Effect of Atorvastatin on Inflammation and Modification of Vascular Risk Factors in Rheumatoid Arthritis
AMAL M. EL-BARBARY, MANAL S. HUSSEIN, ELSAYED M. RAGEH, HALA E. HAMOUDA, AYMAN A. WAGIH, RAGHDA G. ISMAIL
The Journal of Rheumatology Feb 2011, 38 (2) 229-235; DOI: 10.3899/jrheum.100582
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjögren Syndrome Assessed by a Cardiac Magnetic Resonance Approach
  • National Priorities for High-quality Rheumatology Transition Care for Youth in Canada
  • The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis: A Randomized, Double-blind, Placebo-controlled Feasibility Study
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire